Type | Modification enzyme | Site | Biological Functions | Metabolites | Metabolic pathways | Ref. |
---|---|---|---|---|---|---|
Phosphorylation | AMPK | T311 | Disrupts EZH2 interaction with SUZ12, suppresses PRC2 HMTase activity and releases target genes (OLIG2, SOX17, GATA6), resulting in cell cycle arrest and cell differentiation | ATP | Glucose metabolism (glycolysis, etc.) | [78] |
AKT | S21 | Suppresses EZH2 HMTase activity and releases target genes (HOXA9), promoting tumor progression | ATP | Energy metabolism | [79] | |
S21 | Inhbits EZH2 HMTase activity and releases target genes (IGF1, BCL2, HIF1A), leading to the MM cell drug resistance | ATP | Energy metabolism | [83] | ||
S21 | Activates EZH2 as a coactivator for critical transcription factors including the androgen receptor, promoting tumor cells growth | ATP | Energy metabolism | [31] | ||
S21 | Facilitates EZH2-mediated STAT3 methylation and enhances EZH2-STAT3 interaction and STAT3 activity, which accelerates GSC self-renewal and glioblastoma tumor process | ATP | Energy metabolism | [28] | ||
Acetylation | PCAF | K348 | Enhances EZH2 stability and function and the migration and invasion ability of lung cancer | Acetyl-CoA | Fatty acid β-oxidation, TCA cycle, pyruvate and acetate metabolism | [94] |
O-GlcNAcylation | OGT | S75 | Enhances EZH2 stability and function, contributing to tumorigenesis | UDP-GlcNAc | Glucose, amino acids, fatty acids and nucleotide metabolism | [98] |
S73, S76, S84, T313, S729 | Enhance EZH2 stability and function, promoting cancer progression | [99] | ||||
—— | Promotes the migration and invasion of advanced colorectal cancer by enhancing EZH2 stability and activity | [100] |